Exploring the Cortical Hemodynamic Variability of Prefrontal ITBS: a Concurrent TBS/fNIRS Study
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Oct 26, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a technique called intermittent theta-burst stimulation (iTBS) to understand how it affects the brain's ability to change and adapt in healthy individuals. Researchers want to find out why some people respond differently to this stimulation, which is important for improving treatments for various brain-related conditions. By looking at both individual differences and how the brain reacts over time, the study aims to gather valuable information that could help optimize the use of iTBS in the future.
To be eligible for this study, participants should be healthy, able to hear and follow verbal instructions, and have completed at least six years of formal education. However, individuals with a history of psychiatric or neurological disorders, certain medical conditions, or those who are pregnant cannot participate. If you join the study, you can expect to undergo assessments that help researchers understand how your brain responds to the stimulation, contributing to important advancements in brain health research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthiness based on history and psychiatric assessment
- • being able to hear and understand the verbal instructions
- • completed at least 6 years of formal education
- Exclusion Criteria:
- • a current or past diagnosis of psychiatric, neurological disorders, or severe internal illness
- • any conditions that will contraindicate to iTBS or fNIRS
- • psychiatric disorders in their first-degree relatives
- • pregnancy
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Georg Kranz, PhD
Principal Investigator
The Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported